Guru Ownership Trend
Guru Analysis for Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics, Inc. (FULC), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $17.29 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $1.54 M net inflow during the quarter.
Recent activity highlights Cliff Asness who dramatically increased their stake. Conversely, Renaissance Technologies (RenTech) reduced exposure by 21.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Fulcrum Therapeutics, Inc. (FULC)
Major holders include Steven Cohen ($15.91 M), Cliff Asness ($4.17 M), Renaissance Technologies (RenTech) ($104,312). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.63 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.54 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited FULC. The total reported sell value was $2.51 M.
Yes, 0 managers opened new positions in FULC, and 1 increased their existing holdings. The total reported buy value was $4.05 M.